These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 28527916

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.
    Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
    Chen IH, Chang FR, Wu YC, Kung PH, Wu CC.
    Biochimie; 2015 Mar 10; 110():81-92. PubMed ID: 25593085
    [Abstract] [Full Text] [Related]

  • 5. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.
    Zhu X, Wang K, Chen Y.
    Toxicol In Vitro; 2020 Dec 10; 69():104973. PubMed ID: 32818624
    [Abstract] [Full Text] [Related]

  • 6. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z, Delibaşı N, Geçene S, Şener EF, Dönmez-Altuntaş H, Özkul Y, Canatan H, Ozpolat B.
    J Cancer Res Clin Oncol; 2018 Mar 10; 144(3):415-430. PubMed ID: 29288363
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Shrivastava S, Jeengar MK, Thummuri D, Koval A, Katanaev VL, Marepally S, Naidu VGM.
    Biofactors; 2017 Mar 10; 43(2):152-169. PubMed ID: 27580587
    [Abstract] [Full Text] [Related]

  • 9. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K, Son SH, Oh S, Jeon D, Kim H, Noh DY, Kim S, Shin I.
    Oncotarget; 2017 May 30; 8(22):35804-35823. PubMed ID: 28415760
    [Abstract] [Full Text] [Related]

  • 10. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
    Qin J, Tang J, Jiao L, Ji J, Chen WD, Feng GK, Gao YH, Zhu XF, Deng R.
    Life Sci; 2013 Nov 04; 93(18-19):655-63. PubMed ID: 24044886
    [Abstract] [Full Text] [Related]

  • 11. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.
    Huang C, Verhulst S, Shen Y, Bu Y, Cao Y, He Y, Wang Y, Huang D, Cai C, Rao K, Liao DF, Jin J, Cao D.
    Oncotarget; 2016 Jul 12; 7(28):43779-43791. PubMed ID: 27248472
    [Abstract] [Full Text] [Related]

  • 12. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D, Kuang G, Wan J, Zhang X, Li H, Gong X, Li H.
    Oncol Rep; 2017 Feb 12; 37(2):895-902. PubMed ID: 27959422
    [Abstract] [Full Text] [Related]

  • 13. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
    Han JY, Che N, Mo J, Zhang DF, Liang XH, Dong XY, Zhao XL, Sun BC.
    BMC Cancer; 2024 Apr 26; 24(1):532. PubMed ID: 38671389
    [Abstract] [Full Text] [Related]

  • 14. Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling.
    Gautam J, Banskota S, Regmi SC, Ahn S, Jeon YH, Jeong H, Kim SJ, Nam TG, Jeong BS, Kim JA.
    Mol Cancer; 2016 Nov 21; 15(1):75. PubMed ID: 27871326
    [Abstract] [Full Text] [Related]

  • 15. Cadmium promotes the proliferation of triple-negative breast cancer cells through EGFR-mediated cell cycle regulation.
    Wei Z, Song X, Shaikh ZA.
    Toxicol Appl Pharmacol; 2015 Nov 15; 289(1):98-108. PubMed ID: 26385184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 18. ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells.
    Holcakova J, Nekulova M, Orzol P, Nenutil R, Podhorec J, Svoboda M, Dvorakova P, Pjechova M, Hernychova L, Vojtesek B, Coates PJ.
    Breast Cancer Res Treat; 2017 Jun 28; 163(3):475-484. PubMed ID: 28349272
    [Abstract] [Full Text] [Related]

  • 19. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
    Wu J, Liu S, Fan Z, Zhang L, Tian Y, Yang R.
    Tumour Biol; 2016 Jun 28; 37(6):8391-401. PubMed ID: 26733166
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
    Hamamura K, Minami K, Tanjung N, Wan Q, Koizumi M, Matsuura N, Na S, Yokota H.
    Int J Oncol; 2014 Jun 28; 44(6):1980-8. PubMed ID: 24691491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.